ABOUT ADHERON

Adheron is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases.

ABOUT CADHERIN - 11

Cadherin-11 (Cad-11) is a surface protein that acts as an “adhesive” between cells. Therapies targeting Cad-11 may be effective in diseases as diverse as rheumatoid arthritis, fibrosis and cancer.

PARTNERING WITH US

Adheron welcomes the opportunity to explore possible collaborative partnerships.